Skip to Main Content





After studying this chapter you should be able to:

  • Distinguish among the different causes of thrombocytopenia.

  • Understand the pathogenesis of immune thrombocytopenic purpura and the principles of treatment.

  • Understand the pathogenesis of thrombotic thrombocytopenic purpura and the principles of treatment.

  • Define mechanisms that lead to qualitative platelet defects.


Platelets assume an important role in a wide variety of disease states. Morbidity related to platelet dysfunction is generally due to bleeding, but occasionally thrombosis is dominant. As summarized in Table 14-1, bleeding can occur if the platelet count is too low or if there is a qualitative defect in platelet function. In patients with platelet disorders, bleeding is usually superficial and localized to skin and mucous membranes, a phenomenon known as purpura. Petechiae are small, 2-to-5 mm, red or purple macules (spots) that appear most often in the distal lower extremities (Fig. 14-1A) but also on the conjunctiva and palate. Small petechiae often merge to form larger lesions. Very large, purpuric lesions are called ecchymoses (Fig. 14-1B). In contrast to telangiectasia, petechiae and ecchymoses do not blanch under pressure. Mucosal purpura is generally associated with severe thrombocytopenia and may be a harbinger of complications such as gastrointestinal bleeding or even brain hemorrhage. In contrast to the superficial bleeding seen in patients with thrombocytopenia and qualitative platelet disorders, defects in the soluble coagulation factors, such as hemophilia (Table 14-1), typically present with deep bleeding, such as hemarthroses.


Purpura. A) Petechiae on distal lower extremity. B) Ecchymoses.

Graphic Jump Location

Platelet defects:

  • Superficial bleeding

  • Petechiae, ecchymoses

Coagulation factor defects:

  • Deep bleeding

  • Hemarthrosis, etc

Table Graphic Jump Location
TABLE 14-1Overview of Platelet Disorders



In a clear and informative parallel to anemia, thrombocytopenia can be due either to decreased platelet production or enhanced platelet destruction. The life span of normal platelets in the circulation is about 7 to 9 days. Therefore, if the bone marrow stops producing platelets, it takes nearly a week before severe thrombocytopenia develops. In contrast, an acute immune or consumptive process that suddenly and drastically curtails platelet survival can produce severe thrombocytopenia within hours.




Damage or suppression of pluripotent hematopoietic stem cells may result in not only thrombocytopenia but also anemia and leukopenia (pancytopenia) accompanied by marrow aplasia. Aplastic anemia and other causes of pancytopenia are covered in Chapter 4. Transient thrombocytopenia due to ...

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.


About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.